Paul W. Armstrong

University of Alberta — Canada

Medicine · Health Sciences

119h-index82.4kcitations1.3kworks2.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myocardial Infarction Research(512), Cardiac Imaging and Diagnostics(240), Heart Failure Treatment and Management(212), Coronary Interventions and Diagnostics(200), Antiplatelet Therapy and Cardiovascular Diseases(161)

Publications1.3k total

Selection of Reperfusion Therapy and Transfer Strategies for Patients With STEMI
Elsevier eBooks·2025
Rescue percutaneous coronary intervention in the pharmaco-invasive era of ST-elevation myocardial infarction: insights from the STREAM-2 trial
European Heart Journal Acute Cardiovascular Care·2025
Diverse career paths within thrombosis and hemostasis: perspectives from the ISTH early career committee
Journal of Thrombosis and Haemostasis·2025
Phenomapping in Heart Failure With Reduced Ejection Fraction to Identify Subpopulations With High Residual Risk: A VICTORIA Substudy
Circulation Heart Failure·2025Open Access
Geographic Region Variation in Patient Characteristics, Clinical Outcomes and Treatment of HFrEF in the VICTORIA Trial
ESC Heart Failure·2025· 1 citedOpen Access
Assessing Benefit in Patients With Heart Failure and Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification
Journal of Cardiac Failure·2025· 1 cited
Implantable Cardioverter-Defibrillators in Ischaemic Versus Non-Ischaemic Heart Failure: Insights from the VICTORIA Trial
European Journal of Heart Failure·2025· 3 citedOpen Access
Assessing Benefit in Heart Failure Patients with Reduced Ejection Fraction: Analysis of the VICTORIA Trial Using Novel Prognostic Risk Stratification
2025Open Access
Pharmaco-invasive strategy and dosing of tenecteplase in STEMI patients 60 to <75 years: An inter-trial comparison of the STREAM-1 and STREAM-2 trials
American Heart Journal·2025· 1 citedOpen Access
Pharmaco-Invasive Strategy With Half-Dose Tenecteplase in Patients With STEMI: Prespecified Pooled Analysis of Patients Aged ≥75 Years in STREAM-1 and 2
Circulation Cardiovascular Interventions·2024· 4 cited
Projecting the Benefit of Vericiguat in PARADIGM-HF and DAPA-HF populations: Insights from the VICTORIA Trial
ESC Heart Failure·2024· 3 citedOpen Access
THE INFLUENCE OF INFARCT RELATED BASELINE Q WAVES ON ECG METRICS OF REPERFUSION IN STEMI: INSIGHTS FROM THE VHR PRE-HOSPITAL STEMI REGISTRY
Canadian Journal of Cardiology·2024Open Access
Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Elevation Myocardial Infarction: STREAM-2 1-Year Mortality Follow-Up
Circulation·2024Open Access
Comparing Analytical Methods for Composite End Points in Clinical Trials: Insights from the Vericiguat Global Study in Subjects with Heart Failure With Reduced Ejection Fraction Trial
Journal of Cardiac Failure·2024Open Access
Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF
Circulation Heart Failure·2024· 8 cited
Biomarker Profiles Associated with Reverse Ventricular Remodelling in Patients with Heart Failure and a Reduced Ejection Fraction: Insights from the Echocardiographic Substudy of the VICTORIA Trial
European Journal of Heart Failure·2024· 2 citedOpen Access
Global Collaborative Cardiovascular Research: The Collective Wisdom of Countries
Circulation·2024
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status
JACC Heart Failure·2024· 7 citedOpen Access
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes
UNC Libraries·2024Open Access
PHARMACO-INVASIVE STRATEGY WITH HALF-DOSE TENECTEPLASE IN STEMI PATIENTS: PRESPECIFIED POOLED ANALYSIS OF PATIENTS ≥75 YEARS IN STREAM-1 AND 2
Journal of the American College of Cardiology·2024
page 1 of 63Next →

Frequent Co-authors

Elliott M. Antman(12), Harvey D. White(12), Eric J. Topol(11), Frans Van de Werf(11), Judith S. Hochman(10), Harlan M. Krumholz(10), Maarten L. Simoons(10), Lars Wallentin(10), Joseph S. Alpert(9), Robert A. Harrington(9), L. Kristin Newby(8), Christopher B. Granger(8), Eric Bates(7), Lee A. Green(7), Mary M. Hand(7), Gervasio A. Lamas(7), Charles J. Mullany(7), David L. Pearle(7), Michael A. Sloan(7), E. Magnus Ohman(7)